Search

Your search keyword '"Esposito MR"' showing total 37 results

Search Constraints

Start Over You searched for: Author "Esposito MR" Remove constraint Author: "Esposito MR" Search Limiters Full Text Remove constraint Search Limiters: Full Text
37 results on '"Esposito MR"'

Search Results

2. Exome and deep sequencing of clinically aggressive neuroblastoma reveal somatic mutations that affect key pathways involved in cancer progression

4. Multiple clinical forms of dehydrated hereditary stomatocytosis arise from mutations in PIEZO1

5. Hypomorphic mutations of SEC23B gene account for mild phenotypes of congenital dyserythropoietic anemia type II

6. Mutational spectrum in congenital dyserythropoietic anemia type II: Identification of 19 novel variants in SEC23B gene

7. Molecular analysis of 42 patients with congenital dyserythropoietic anemia type II: new mutations in the SEC23B gene and a search for a genotype-phenotype relationship

8. Two founder mutations in the SEC23B gene account for the relatively high frequency of CDA II in the Italian population

9. Missense mutations in the ABCB6 transporter cause dominant familial pseudohyperkalemia

10. Clinical aspects and pathogenesis of congenital dyserythropoietic anemias: From morphology to molecular approach

11. Cytotoxic effects induced by combined exposure to the mycotoxins sterigmatocystin, ochratoxin A and patulin on human tumour and healthy 3D spheroids.

12. Telehealth vs in-person education for enhancing self-care of ostomy patients (Self-Stoma): Protocol for a noninferiority, randomized, open-label, controlled trial.

13. Comparative Study of Spheroids (3D) and Monolayer Cultures (2D) for the In Vitro Assessment of Cytotoxicity Induced by the Mycotoxins Sterigmatocystin, Ochratoxin A and Patulin.

14. The Growing Importance of Three-Dimensional Models and Microphysiological Systems in the Assessment of Mycotoxin Toxicity.

15. miR-210-3p enriched extracellular vesicles from hypoxic neuroblastoma cells stimulate migration and invasion of target cells.

16. Development of an in vitro neuroblastoma 3D model and its application for sterigmatocystin-induced cytotoxicity testing.

17. Evaluation of soft skills among Italian Healthcare Rehabilitators: A cross sectional study.

18. Influenza vaccination and healthcare workers: barriers and predisposing factors.

19. A Psychometric Validation of the Decisional Conflict Scale in Italian Cancer Patients Scheduled for Insertion of Central Venous Access Devices.

20. An investigation into Video Game Addiction in Pre-Adolescents and Adolescents: A Cross-Sectional Study.

21. An investigation on parenting stress of children with cystic fibrosis.

22. Patient-derived organoids (PDOs) as a novel in vitro model for neuroblastoma tumours.

23. The CiTAS scale for evaluating taste alteration induced by chemotherapy: state of the art on its clinical use.

24. Chromosome instability in neuroblastoma.

25. Knowledge, attitudes, and practice on the prevention of central line-associated bloodstream infections among nurses in oncological care: A cross-sectional study in an area of southern Italy.

26. Neuroblastoma treatment in the post-genomic era.

27. Combating autophagy is a strategy to increase cytotoxic effects of novel ALK inhibitor entrectinib in neuroblastoma cells.

28. Deregulation of focal adhesion pathway mediated by miR-659-3p is implicated in bone marrow infiltration of stage M neuroblastoma patients.

29. Multiple clinical forms of dehydrated hereditary stomatocytosis arise from mutations in PIEZO1.

30. Inherited hematological disorders due to defects in coat protein (COP)II complex.

31. Missense mutations in the ABCB6 transporter cause dominant familial pseudohyperkalemia.

32. Clinical aspects and pathogenesis of congenital dyserythropoietic anemias: from morphology to molecular approach.

33. Two founder mutations in the SEC23B gene account for the relatively high frequency of CDA II in the Italian population.

34. Congenital dyserythropoietic anaemias: new acquisitions.

35. Mutational spectrum in congenital dyserythropoietic anemia type II: identification of 19 novel variants in SEC23B gene.

36. Molecular analysis of 42 patients with congenital dyserythropoietic anemia type II: new mutations in the SEC23B gene and a search for a genotype-phenotype relationship.

37. A novel erythroid anion exchange variant (Gly796Arg) of hereditary stomatocytosis associated with dyserythropoiesis.

Catalog

Books, media, physical & digital resources